Market Overview

Morgan Stanley Reiterates Equal-Weight Rating on Molycorp

Related MCP
Molycorp Hits All-Time Lows On Takeover Concerns
Stocks Hitting 52-Week Lows

In a report published Friday, Morgan Stanley reiterated its Equal-Weight rating on Molycorp (NYSE: MCP).

Morgan Stanley noted, “No update on ramp up at Project Phoenix suggests costs could remain high in 4Q while REO prices declined ~26% to $24/kg. As demand remains weak, we see near-term risk to margins until production rate moves above ~15ktpy. Lowering 4Q EPS estimate to $(0.20). 4Q rebound in earnings looks unlikely. Lack of an update about ramp up at Project Phoenix raises the risk of costs remaining high in 4Q. Additionally, with average REO prices 19% below 3Q on one month lag, we do not expect 4Q earnings to rebound.”

Molycorp closed on Thursday at $9.30.

Posted-In: Morgan StanleyAnalyst Color Reiteration Analyst Ratings

 

Most Popular

Related Articles (MCP)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional